Research Impact Case Study 2: College of Life Sciences & Medicine, University of Aberdeen


Published on

Given as part of ACES/CSID workshop on "Achieving Research Impact" at the University of Aberdeen in January 2011

Published in: Education
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Research Impact Case Study 2: College of Life Sciences & Medicine, University of Aberdeen

  1. 1. Immpact is the internationalresearch Initiative for Maternal Mortality Programme Assessment Sept 2002- to date Goal: to improve the evidence-base for decision-makers on strategies to reduce maternal & newborn mortality
  2. 2. • Funded by DFID, Bill & Melinda Gates Foundation, USAID • Total award 2002-2008: £20m – largest single award ever made to University of Aberdeen• 7 partner research institutions in North and South (grantholder and co-ordinating centre at University of Aberdeen)• At height of field activity, 250 people employed, mostly in 3low income countries. Max staff at UoA 50.
  3. 3. Project cycle 2002-2008+ I. Aim: strengthen the evidence-base on mortality reduction strategies II. Main outputs:IV. Facilitating • New tools; uptake of • Evidence from research complex evaluations in outputs 3 main countries (+ 5); • Strengthened research capacity; III. Dissemination & • Technical advisory communication arm (Ipact).
  4. 4. Crucial GRIPP stepResearch Knowledge- Evidence Policy-priority- generation & translation makingsetting dissemination processes GRIPP: Getting research into policy and practiceSource: Alliance for Health Policy and Systems Research. 2007.
  5. 5. Who should do translation of research evidence?Knowledge brokers aim to provide evidence that isaccessible, timely, credible and trusted, and packaged inuser-friendly format, relevant to the local context.Knowledge brokers work at the interface between researchorganizations and their target audiences.
  6. 6. “The role of the scientist is to use research to ascertain the effectiveness of innovative policies and programs.This is in contrast to {their} role as advisor in which the scientist can indulge in over-advocacy ...”. Donald T Campbell 1988 The experimenting society.
  7. 7. 7
  8. 8. Different worlds, different “communities” Researchers are from Venus. Policy makers are from Mars.
  9. 9. Stakeholders for research evidence are diverse Media Funding Research Think Government bodies institutions tanks bodies Advocates, civil society, NGOs, parliamentarians
  10. 10. Conventional research outputs:•120 journal publications; 3 special journal supplements; 1 book;•1 international conference; 3 national conferences;•12 policy briefs;• 3 websites (+open access to data);•1 toolkit of measurement instruments;• 5 PhDs; 7 masters degrees;• Country reports in English, French & Bahasa;• CD-based interactive inventory of materials;• 45 presentations or posters at international conferences.• short course on monitoring and evaluation (Ipact);
  11. 11. Viral film: Birth &
  12. 12. PUBLIC ENGAGEMENT WHO, 2004 “Four births and a funeral” (or children sitting on
  13. 13. “Quality facilitydeliveries”“Ensuring that the carereceived is good qualitywill enable substantialadditional benefits to bereaped in terms of fewerdeaths to mothers& babies.” (p.50)
  14. 14. “Free quality services forwomen and children atthe point of use …..”(p.53)“Strong evaluationtechniques.. ..tomeasure progress inimplementing qualityMNCH services andcosts, as well as … livessaved.” (p.54)
  15. 15. Launched 22nd Sept 2010University of Aberdeen – one of only 14 academic institutionsinvited by Ban Ki Moon to publically endorse new GlobalStrategy
  16. 16. In the next 20 years, India isprojected to become the mostpopulous nation in the worldIndia currently contributes a fifthof the global total of maternaldeathsImmpact recently invited tosupport the GOI in design &implementation of a Road Map toimprove quality of delivery care ininstitutions
  17. 17. Creating an enabling environment for GRIPP• Start from perspective of • Capitalise on personaldecision-makers/end-users contacts, trust & credibility• Ensure continuity of • Timely findings (planning orlinkages & exchange budget cycles; reforms) • Communicate effectively• Promote multiple pathways (filtered/amplified evidence;to GRIPP & form strategic tailored messaging)alliances